| Literature DB >> 22350112 |
Eduard R Felder1, Alessandra Badari, Teresa Disingrini, Sergio Mantegani, Christian Orrenius, Nilla Avanzi, Antonella Isacchi, Barbara Salom.
Abstract
The generation of novel chemotypes in support of our oncology research projects expanded in recent years from a canonical design of kinase-targeted compound libraries to a broader interpretation of purinome-targeted libraries (PTL) addressing the specificity of cancer relevant targets such as kinases and ATPases. Successful screening of structurally diverse ATP-binding targets requires compound libraries covering multiple design elements, which may include phosphate surrogate moieties in ATPase inhibitors or far reaching lipophilic residues stabilizing inactive kinase conformations. Here, we exemplify the design and preparation of drug-like combinatorial libraries and report significantly enhanced screening performance on purinomic targets. We compared overall hit rates of PTL with a simultaneously tested unbiased collection of 200,000 compounds and found consistent superiority of the targeted libraries in all cases. We also analyzed the performance of the largest targeted libraries in comparison with each other and often found striking differences in how a specific target responds to various chemotypes and to whole collections.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22350112 DOI: 10.1007/s11030-012-9361-6
Source DB: PubMed Journal: Mol Divers ISSN: 1381-1991 Impact factor: 2.943